Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Quan-liang Yang
Rechallenge and Maintenance Therapy Using Cetuximab and Chemotherapy Administered to a Patient With Metastatic Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-Line Cetuximab and Irinotecan
JAMA Oncology
Cancer Research
Oncology
Rechallenge Therapy and Treatment Holiday: Different Strategies in Management of Metastatic Colorectal Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer
International Journal of Cancer
Cancer Research
Oncology
P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Real-World Effect of Maintenance and Intermittent Chemotherapy on Survival in Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
A Study of Capecitabine Metronomic Chemotherapy Is Non-Inferior to Conventional Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer
Trials
Medicine
Pharmacology
Mechanism of Resistance to Cetuximab Therapy in Colorectal Cancer
mAbs
Allergy
Immunology
Cetuximab Retreatment in Patients With Metastatic Colorectal Cancer Who Exhibited a Clinical Benefit in Response to Prior Cetuximab: A Retrospective Study
Oncology Letters
Cancer Research
Oncology
Current Status of Treatment of Metastatic Colorectal Cancer With Special Reference to Cetuximab and Elderly Patients
OncoTargets and Therapy
Oncology
Pharmacology